However, despite a previously published article predicting that ITGB4 may be overexpressed at mRNA level in ccRCC [27], studies so far have neither validated its expression condition nor demonstrated any of its biological functions and molecular mechanisms in this cancer. This evidence concerns the gene ITGB4 and nonpapillary renal cell carcinoma.